The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), intends to award a non-competitive contract for an Essential Support Plan for the Thermo Fisher nanoLC-Lumos Mass Spectrometer. This procurement aims to secure a service contract for the maintenance and support of the mass spectrometer, which is critical for the operations of the NIH’s Proteomics Core Facility, providing essential protein analysis services. The contract will cover a period from December 10, 2024, to December 9, 2029, ensuring continued functionality of the equipment, as Thermo Fisher is the only authorized provider for these services due to proprietary rights and specialized training of their engineers. Interested parties may submit capability statements to Kelly Dempsey at kelly.dempsey@nih.gov by December 5, 2024, at 12 PM Eastern Time, to be considered for this opportunity.